Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Stanley

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|January 22, 2013
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activityCharity Atkins, Qi Liu, Elisabeth Minthorn, et al.
Journal of Virology|February 14, 2004
Identification of peptides that inhibit the DNA binding, trans-activator, and DNA replication functions of the human papillomavirus type 11 E2 proteinSu-Jun Deng, Kenneth H Pearce, Eric P Dixon, et al.
Journal of Medicinal Chemistry|February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonistBarry G Shearer, Robert W Wiethe, Adam Ashe, et al.
Cell|August 2, 2002
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognitionRandy K Bledsoe, Valerie G Montana, Thomas B Stanley, et al.
Journal of Medicinal Chemistry|March 30, 2010
Discovery of tertiary sulfonamides as potent liver X receptor antagonistsWilliam J Zuercher, Richard G Buckholz, Nino Campobasso, et al.
Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.
Plos One|August 10, 2022
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|January 22, 2013
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activityCharity Atkins, Qi Liu, Elisabeth Minthorn, et al.
Journal of Virology|February 14, 2004
Identification of peptides that inhibit the DNA binding, trans-activator, and DNA replication functions of the human papillomavirus type 11 E2 proteinSu-Jun Deng, Kenneth H Pearce, Eric P Dixon, et al.
Journal of Medicinal Chemistry|February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonistBarry G Shearer, Robert W Wiethe, Adam Ashe, et al.
Cell|August 2, 2002
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognitionRandy K Bledsoe, Valerie G Montana, Thomas B Stanley, et al.
Journal of Medicinal Chemistry|March 30, 2010
Discovery of tertiary sulfonamides as potent liver X receptor antagonistsWilliam J Zuercher, Richard G Buckholz, Nino Campobasso, et al.
Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.
Plos One|August 10, 2022
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Pageof 2